Paper
Paper
Biotransformation of the topical glucocorticoids budesonide and beclomethasone
Andersson P, Ryrfeldt A. Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17 alpha,21 dipropionate in human liver and lung homogenate. J Pharm Pharmacol 1984;36:763-765.
Paper
Beclomethasone Dipropionate
Brogden RN, Heel RC, Speight TM et al. Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs. 1984;29: 99-126.
Paper
Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis.
Brogden RN, Heel RC, Speight TM and Avery GS. Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs. 1984;29:99-126.
Paper
Acute side effects and late complications after radiotherapy of localized carcinoma of the prostate
Dewit L., Ang KK, Van der Schueren, E. Acute side effects and late complications after radiotherapy of localized carcinoma of the prostate. Cancer Treatment Reviews. 10: 79-89, 1993.
Paper
Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man
Johansson SA, Andersson KE, Brattsand R et al. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Respir Dis Suppl. 1982;22:523-529.
Paper
Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man
Johansson SA, Andersson KE, Brattsand R et al. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Respir Dis Suppl. 1982;22:523-529.
Paper
Beclomethasone Dipropionate Enemas for Treating Inflammatory Bowel Disease Without Producing Cushing’s Syndrome or Hypothalamic Pituitary Adrenal Supression
Kumana CR, Seaton T, Meghji M et al. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. Lancet. 1982;1:579-583.
Paper
Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing’s syndrome or hypothalamic pituitary adrenal suppression
Kumana CR, Seaton T, Meghji M, Castelli M, Benson R and Sivakumaran T. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. Lancet. 1982;1: 579-583.
Paper
Metabolism of beclomethasone 17,21-dipropionate
Oishi T, Deguchi T, Marumo H. Metabolism of beclomethasone 17,21-dipropionate. Appl Pharmacol. 1981;22:717-727.
Paper
Metabolic fate of beclomethasone 17,21-dipropionate in the rat
Oishi T, T Deguchi, H Marumo Metabolic fate of beclomethasone 17, 21-dipropionate in the rat. Pharmacometrics. 1981;22:717-27